Gilead is teaming up with Vir on solid tumor cancer drugs in a deal worth up to $1.9 billion
- VIR: 2 events in the last 90 days
- Previous: 52 days earlier · IMSA 2026 VIR results, points: Pfaff Motorsports, Winward Racing continue winning streaks
What happened
Vir Biotechnology will receive $90 million upfront and could earn up to $1.74 billion in later milestone payments
Summary assembled by rule from the sources below